Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739315

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739315

Automated Drug Kiosks

PUBLISHED:
PAGES: 164 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Automated Drug Kiosks Market to Reach US$27.3 Billion by 2030

The global market for Automated Drug Kiosks estimated at US$11.6 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Automated Drug Kiosk Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$19.6 Billion by the end of the analysis period. Growth in the Automated Drug Kiosk Services segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 14.3% CAGR

The Automated Drug Kiosks market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.4% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Automated Drug Kiosks Market - Key Trends & Drivers Summarized

Why Are Automated Drug Kiosks Emerging as Scalable Solutions for Accessible Pharmaceutical Dispensing?

Automated drug kiosks are transforming medication access by offering secure, self-service alternatives to traditional pharmacy counters. These kiosks provide round-the-clock availability of prescription and over-the-counter drugs in hospitals, clinics, airports, and remote locations-streamlining last-mile pharmaceutical delivery while addressing pharmacist shortages and wait-time challenges. Designed to dispense pre-packaged medications via electronic authorization and identity verification, these systems enhance convenience for patients while ensuring regulatory compliance and controlled access.

Healthcare providers and retail pharmacies are increasingly deploying these kiosks to expand service reach without incurring full operational costs associated with brick-and-mortar expansions. As telehealth adoption accelerates, automated kiosks are becoming critical touchpoints that bridge virtual consultations with physical medication fulfillment. Their integration into electronic health record (EHR) systems enables seamless, point-of-care dispensing, improving medication adherence and reducing delays in treatment initiation.

How Are Technological Innovations Enhancing the Safety, Compliance, and Integration Capabilities of Drug Kiosks?

Modern automated drug kiosks are equipped with advanced safety protocols, biometric authentication, and real-time monitoring to ensure secure and compliant dispensing. Integration with pharmacy management software and cloud-based platforms allows pharmacists to remotely approve prescriptions, track inventory, and manage refill cycles. Video conferencing modules are also being added to facilitate on-demand pharmacist consultations, preserving patient-pharmacist interaction while maintaining kiosk autonomy.

Regulatory-aligned features such as tamper detection, temperature control, and audit-ready tracking are positioning kiosks as compliant solutions even for sensitive or controlled medications. Integration with insurance databases and e-prescription systems enables eligibility verification and copay processing directly at the kiosk. As interoperability with broader digital health ecosystems strengthens, these kiosks are evolving into smart, decentralized pharmacy nodes capable of supporting both outpatient and chronic care workflows.

Where Is Adoption of Automated Drug Kiosks Accelerating and What Use Cases Are Driving Growth?

Adoption is gaining momentum in healthcare systems facing resource constraints, particularly in rural and underserved areas where pharmacy access is limited. Hospitals and urgent care centers are implementing kiosks to provide post-discharge or after-hours medication access, reducing readmission risks and improving continuity of care. Retail pharmacy chains are piloting kiosks in high-traffic public spaces-such as malls, airports, and campuses-to offer instant access to common medications and wellness products.

Government healthcare programs and humanitarian organizations are exploring kiosk deployments as part of public health outreach in remote and low-income regions. Additionally, large employers and universities are adopting these systems within wellness centers to streamline workforce health management. Use cases are also expanding into correctional facilities, senior living communities, and military bases-where controlled, trackable, and efficient dispensing is essential.

What Is Fueling the Global Expansion of the Automated Drug Kiosks Market?

Market growth is being driven by rising healthcare consumerism, cost-containment pressures, and digital transformation mandates across pharmacy services. Patients increasingly demand convenience, privacy, and 24/7 access, which kiosks can deliver at a fraction of traditional dispensing costs. The pandemic-era shift toward contactless service models further validated the role of automated dispensing in enhancing resilience and accessibility in pharmaceutical care.

Pharmacy chains, health systems, and medtech companies are forming partnerships to scale deployment and standardize integration with existing clinical and pharmacy workflows. Regulatory bodies are gradually updating guidelines to accommodate remote dispensing models, encouraging broader acceptance. As healthcare becomes more decentralized and patient-centric, a core question gains urgency: Can automated drug kiosks become the backbone of last-mile medication delivery in a system striving for greater equity, efficiency, and adherence?

SCOPE OF STUDY:

The report analyzes the Automated Drug Kiosks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Systems, Services); Drug Type (Prescriptions, Over-The-Counters, Other Drug Types); End-Use (Retail Pharmacies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Asteres Inc.
  • Bell and Howell
  • BestKiosk
  • Capsa Healthcare
  • Diebold Nixdorf
  • Distributed Delivery Networks Corp.
  • Higi
  • Howell LLC
  • ImageHOLDERS
  • Jadak
  • MC HealthGrid Pvt Ltd.
  • MedAvail Technologies Inc.
  • MedfriendRx
  • Omnicell Inc.
  • PharmcoRx
  • PickPoint
  • Rowa Automatisierungssysteme GmbH
  • ScriptPro LLC
  • Smart RX Systems Inc.
  • Stericycle Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Product Code: MCP33481

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Automated Drug Kiosks - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • 24/7 Dispensing Capability Positions Automated Drug Kiosks as a Pillar of Healthcare Accessibility
    • Integration With e-Prescriptions and EMRs Streamlines Pharmacy Workflow Through Drug Kiosks
    • Retail and Rural Healthcare Expansion Drives Adoption of Automated Drug Dispensing Kiosks
    • Pandemic-Era Contactless Health Trends Accelerate Public Acceptance of Automated Drug Kiosks
    • Regulatory Support for Remote Pharmaceutical Dispensing Enhances Legitimacy of Drug Kiosks
    • Insurance and Reimbursement Integration Improves Affordability of Medications Via Drug Kiosks
    • Compact Footprint and Low Operational Costs Make Automated Drug Kiosks Attractive to Pharmacies
    • AI-Enabled Inventory Management Increases Efficiency and Reduces Stockouts in Drug Kiosks
    • Deployment in Transit Hubs and Workplaces Expands Reach of Automated Drug Kiosk Services
    • Real-Time Access to High-Demand Medications Improves Chronic Disease Adherence Rates
    • Integration With Telepharmacy Platforms Expands Scope of Services Delivered Via Drug Kiosks
    • Automated Drug Kiosks Play a Strategic Role in Decentralizing Healthcare Distribution Networks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Drug Kiosks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Prescriptions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Prescriptions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Over-The-Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Over-The-Counters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Automated Drug Kiosks by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Automated Drug Kiosks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Product Type - Systems and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Automated Drug Kiosks by Product Type - Percentage Breakdown of Value Sales for Systems and Services for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by Drug Type - Prescriptions, Over-The-Counters and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Automated Drug Kiosks by Drug Type - Percentage Breakdown of Value Sales for Prescriptions, Over-The-Counters and Other Drug Types for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Automated Drug Kiosks by End-Use - Retail Pharmacies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Automated Drug Kiosks by End-Use - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!